SMC4 was highly expressed in patients with glioma, and elevated SMC4 expression was associated with tumor progression and poor overall survival in patients with glioma, indicating that SMC4 overexpression promotes glioma cell aggressiveness and represents a novel, valuable prognostic indicator of outcome in patients with glioma. This evidence concerns the gene SMC4 and central nervous system cancer.